Two Growth Stocks to Consider for Long-Term Investors
-
The stock market can be unpredictable, but buying shares of great companies at fair prices and holding long-term is a good strategy.
-
PubMatic is an ad tech company growing revenue double digits despite industry challenges. It's profitable and reasonably priced.
-
TransMedics is changing organ transplants with its FDA-approved organ care system and transportation capabilities. Growth is rapid.
-
PubMatic trades at 21x free cash flow. TransMedics trades at 11x sales with expected 49-53% growth this year.
-
Both stocks look like smart long-term buys for growth-minded investors, even with just $100 to invest.